• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,772.55(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bharat Parenterals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
940.00 -30 (-3.09%)
  • As on 25 Apr 2025 (EOD)
  • Today’s Low

    921.50
  • Today’s High

    998.00
  • Open

    998.00
  • Perv Close

    970.00
  • 52W Low

    802.00
  • 52W High

    1,870.00

Key Indicators

  • P/E(TTM)

    23.79

  • Mar.Cap (₹Cr.)

    647.84

  • Div & Yield %

    0.09

  • Book Value(₹)

    548.29

  • Debt-Equity Ratio

    -3.09

  • AGM Date

    25-Apr-2025

  • EPS

    39.52

  • P/E Ratio

    23.79

Financials Ratios

  • Debt-Equity Ratio

    0.55

  • Mar.Cap (₹Cr.)

    647.84

  • RONW (%)

    5.53

  • ROCE (%)

    7.71

Score Board

  • Equity (₹ in Cr.)

    6.89

  • BV (₹)

    548.30

  • Sales( ₹ in Cr.)

    254.16

  • NP (in Cr.)

    22.63

  • NP Var(%)

    14.0

  • Div%

    10.0

  • CPS (₹)

    42.10

  • EPS (₹)

    32.80

  • Traded Value (₹ in Lakhs)

    668.52

  • 52 Week High

    1,870.00

  • 52 Week Low

    802.00

  • Price BSE

    970.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    668.52

  • P/C Ratio

    23.00

  • P/E Ratio

    29.50

  • Price Vs.BV

    32.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 283.24 252.73 240.92 203.67 226.33 219.69
Excise Duty 29.08 34.75 28.91 0.00 0.00 0.00
Net Sales 254.16 217.98 212.01 203.67 226.33 219.69
Other Income 11.96 18.84 7.78 8.67 11.48 12.70
Stock Adjustments 15.19 9.75 -1.68 -1.88 3.27 0.19
Total Income 281.31 246.57 218.11 210.46 241.08 232.58
EXPENDITURE :            
Raw Materials 173.57 147.23 134.39 132.16 150.50 141.34
Power and Fuel Cost 4.24 3.73 2.98 3.10 3.19 2.70
Employee Cost 19.61 16.93 15.26 14.39 14.11 14.27
Other Manufacturing Expenses 11.29 10.06 7.42 6.39 7.00 7.18
Selling and Administration Expenses 26.00 23.54 13.82 13.77 20.90 21.15
Miscellaneous Expenses 5.47 4.50 7.91 6.85 3.68 3.01
Employee Benefit Expenses 19.61 16.93 15.26 14.39 14.11 14.27
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 240.17 205.99 181.78 176.66 199.38 189.67
Operating Profit 41.13 40.59 36.34 33.81 41.70 42.92
Interest 3.93 2.57 1.31 0.76 0.86 0.87
Gross Profit 37.20 38.02 35.03 33.05 40.84 42.05
Depreciation 6.40 5.85 6.66 6.03 5.88 6.13
Profit Before Tax 30.80 32.17 28.37 27.02 34.96 35.92
Current Tax 8.66 8.40 8.01 7.09 9.82 7.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.45 -0.57 -0.94 -0.28 -1.17 5.59
Reported Net Profit 22.59 24.34 21.30 20.21 26.30 22.57
Extraordinary Items -0.03 4.55 -0.53 0.16 -0.30 0.01
Adjusted Net Profit 22.62 19.79 21.83 20.05 26.60 22.56
Adjustment below Net Profit -0.20 0.04 -0.23 0.16 0.04 -0.09
P & L Balance brought forward 183.19 158.81 137.74 117.37 91.03 68.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.43 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 205.16 183.19 158.81 137.74 117.37 91.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 7.50 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 0.75 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 38.82 42.14 36.89 35.27 45.90 39.40
Earnings Per Share(Adj)-Unit Curr 38.82 42.14 36.89 35.27 45.90 39.40
Book Value 367.05 330.86 287.72 251.22 214.92 168.95
Book Value(Adj)-Unit Curr 367.05 330.86 287.72 251.22 214.92 168.95

Shareholding Pattern

  • Promoter Group

    67.20%

  • Public Share Holding

    32.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,883,261 27.33 1,883,261 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 2,747,797 39.87 2,747,797 2
Sub Total 4,631,058 67.20 4,631,058 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,500 0.11 7,500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36,862 0.53 36,862 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 44,862 0.65 44,362 3
2] Non Institution
Bodies Corporate 583,390 8.46 234,860 41
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 256,118 3.72 248,418 58
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 70,157 1.02 66,957 94
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 396,986 5.76 396,986 6
Individuals holding nominal share capital up to Rs. 1 lakh 908,641 13.18 715,716 2,965
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 751 0.01 751 1
Others 0 0.00 0 0
Sub Total 2,216,043 32.15 1,663,688 3,165
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,891,963 100.00 6,339,108 3,177

Company Background

Bharat Parenterals LtdPharmaceuticals - Indian - Formulations

  • Bharat Parenterals Ltd
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
  • Incorporation Year

    1992

  • Registered Office

    Survey No 144 & 146 Haripura
    Jarod Samlaya Road Tal Savli, Vadodara,
    Gujarat-391520

  • Telephone

    91-2667-251679

  • FAX

    91-2667-251670

  • Chairman

  • Managing Director

    Bharat Kumar R Desai

  • Company Secretary

  • Auditor

    CNK & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corporate Serv. Pvt Ltd
    205/206 Sterling Cen,
    R C Dutt Road ,Alkapuri
    Mumbai - Vadodara - 390007

Bharat Parenterals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bharat Parenter. 940.00 266.11 283.24 23.79 12.94
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92